Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS.
about
New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?Cetrotide administration in the early luteal phase in patients at high risk of ovarian hyperstimulation syndrome: A controlled clinical study.The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndromeSerum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?GnRH analogues in the prevention of ovarian hyperstimulation syndromeA new way of setting rFSH deposit: a case of severe injection error in IVF/ICSI cycle ending with live birth.What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.The effect of cabergoline on folicular microenviroment profile in patients with high risk of OHSS.Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation.Ovarian follicular development stimulated by leuprorelin acetate plus human menopausal gonadotropin in chimpanzees.A case of ovarian enlargement in severe primary hypothyroidism and review of the literature.Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI.The decline in serum estradiol on the second day after oocyte retrieval affects the outcome of IVF/ICSI-ET treatment in high ovarian responders.GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome.
P2860
Q24629517-87511FC6-459F-4AC5-8BA3-EB91CD8BFF26Q34443933-60642E7E-CAF3-4ADF-B8F5-4117A0F0A1EEQ35071420-BAF6B10C-EF08-4730-A794-7D1E6A67776DQ35621462-1362E84C-68DA-4F11-AFB8-2E68248CC016Q35808082-256D910C-A15D-49AD-8D54-E8AF3B1D2373Q36085346-9D79C5C4-BBFF-499C-81C4-4EC3C6173501Q36957480-F476CA35-C1E7-4CD2-B4F9-AAC316C29799Q37611308-485EA383-7267-4B41-B55A-008F62DD1FE7Q38677963-0E2DE94F-F654-49EA-B0C2-2EA5CED2BB8FQ44458778-23D42250-5185-49F1-8900-53E1C378A07EQ45423271-10E8F717-5C03-4C64-8259-55EABFD3C153Q46462488-A4B264F2-E16B-441D-BBEC-8661E3514AFFQ46978995-BC773DE4-B668-42D4-9569-CC1DD4FAC5F1Q47103208-75F0D805-A95E-47AF-9CF6-7AB87C52A611Q47421840-98DEF826-8F4E-43CB-8E54-9B02B31DC307Q48703957-E6FF66D9-9EC6-40DF-8581-F9A851F7F8FDQ48784220-60749643-EEB2-4DA5-80CD-90D1989C566BQ50645058-B5150684-5A40-4C09-9CDD-8FB04EEB8FC0
P2860
Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prediction of ovarian hypersti ...... ole in the prediction of OHSS.
@ast
Prediction of ovarian hypersti ...... ole in the prediction of OHSS.
@en
type
label
Prediction of ovarian hypersti ...... ole in the prediction of OHSS.
@ast
Prediction of ovarian hypersti ...... ole in the prediction of OHSS.
@en
prefLabel
Prediction of ovarian hypersti ...... ole in the prediction of OHSS.
@ast
Prediction of ovarian hypersti ...... ole in the prediction of OHSS.
@en
P356
P1433
P1476
Prediction of ovarian hypersti ...... ole in the prediction of OHSS.
@en
P2093
Mohamed Aboulghar
P304
P356
10.1093/HUMREP/DEG208
P407
P577
2003-06-01T00:00:00Z